BehaVR

BehaVR develops virtual reality digital therapeutics for mental and behavioral health, translating proven science into immersive XR experiences that help people work through stress, anxiety, and fear toward improved well-being. The platform's programs are designed to help people take real steps forward in their mental health journey across focus areas including mental wellness, anxiety regulation, pain management, addiction recovery, serious mental illness, and maternal health. All solutions incorporate education, mindfulness, and meta-cognition to help individuals confront traumas, triggers, and fears in a safe virtual space. BehaVR collaborates with leading healthcare institutions including Johns Hopkins HealthCare on CenteredVR for stress reduction, Sumitomo Pharma for behavioral mental health therapies, and the University of Utah on NIH-funded Mindfulness-Oriented Recovery Enhancement programs for opioid use disorder. The platform serves individuals, patients, employees, and health plan members through VR-based care experiences. Founded in 2016 and headquartered in Elizabethtown, Kentucky, the company has raised approximately $20.7M in Series B funding from investors including Accenture, Optum Ventures, Oxford Science Enterprises, Chrysalis Ventures, Confluent Health, Thornton Capital, and HHS. BehaVR differentiates itself through its evidence-based VR therapeutics platform that makes mental healthcare accessible through immersive experiences validated by clinical research partnerships.